|
NSMCE1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.23800000437913E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.54839999999545E-06 |
| Normal-vs-Stage2 |
1.568160E-01 |
| Normal-vs-Stage3 |
2.883500E-03 |
| Normal-vs-Stage4 |
1.385760E-04 |
| Stage1-vs-Stage2 |
8.737700E-02 |
| Stage1-vs-Stage3 |
2.341400E-01 |
| Stage1-vs-Stage4 |
9.747800E-01 |
| Stage2-vs-Stage3 |
4.591000E-01 |
| Stage2-vs-Stage4 |
1.108780E-01 |
| Stage3-vs-Stage4 |
2.882600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.53189999965819E-07 |
| Normal-vs-AfricanAmerican |
1.000710E-03 |
| Normal-vs-Asian |
4.869600E-01 |
| Caucasian-vs-AfricanAmerican |
9.313200E-01 |
| Caucasian-vs-Asian |
7.296600E-01 |
| AfricanAmerican-vs-Asian |
6.120800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.48800000005145E-06 |
| Normal-vs-Female |
4.46470000003973E-06 |
| Male-vs-Female |
9.089000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.902200E-02 |
| Normal-vs-Age(41-60Yrs) |
4.76309999997149E-07 |
| Normal-vs-Age(61-80Yrs) |
2.592300E-04 |
| Normal-vs-Age(81-100Yrs) |
1.147440E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.561200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.340600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.658800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.112400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.670200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.692200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.924800E-03 |
| Normal-vs-Grade 2 |
1.161100E-04 |
| Normal-vs-Grade 3 |
1.25169999998231E-06 |
| Normal-vs-Grade 4 |
4.357200E-03 |
| Grade 1-vs-Grade 2 |
9.898800E-01 |
| Grade 1-vs-Grade 3 |
9.345000E-01 |
| Grade 1-vs-Grade 4 |
9.860000E-01 |
| Grade 2-vs-Grade 3 |
8.597400E-01 |
| Grade 2-vs-Grade 4 |
9.938800E-01 |
| Grade 3-vs-Grade 4 |
8.935800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.99820000440698E-08 |
| Normal-vs-ccB subtype |
7.370400E-02 |
| ccA subtype-vs-ccB subtype |
2.760400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.94829999999558E-05 |
| Normal-vs-N1 |
9.170000E-02 |
| N0-vs-N1 |
8.616600E-01 |
|
|
